*Result Highlight*
Glaxosmithkline Pharmaceuticals Ltd. Q4 Cons: Net profit down -6% at Rs. 138.07 cr. Vs Rs. 146.81 cr. (YoY) and Revenue up 3.3% at Rs. 775.8 cr. Vs Rs. 750.81 cr. (YoY)
Board of Directors recommend a Dividend of Rs 40 per equity share of face value of Rs.10 each which includes a special dividend of Rs. 20 per share for this year. (Year ended 31st March 2019 Rs.20 per share).
Torrent Power Ltd. Q4 Cons: Net loss at Rs. -274.92 cr. (due to an exceptional item, company made a provision of Rs 1,000 crore as exceptional item in the quarter towards carrying cost of DGEN plant Dahej, Gujarat) Vs profit of Rs. 23.95 cr. (YoY) and Revenue up 2% at Rs. 2983.5 cr. Vs Rs. 2924.8 cr. (YoY)
Astrazeneca Pharma India Ltd. Q4: Net profit down -2.5% at Rs. 9.57 cr. Vs Rs. 9.82 cr. (YoY) and Revenue up 2.4% at Rs. 194.9 cr. Vs Rs. 190.3 cr. (YoY)
Dr. Lal PathLabs Ltd Q4 Cons: Revenue was flat yoy however declined 8% qoq at Rs 301.7 cr impacted covid-19 lockdown as volumes were lower. Net profit declined 31% yoy & 41% qoq at Rs 32.6 cr.
Delta Corp Ltd. Q4 Cons: Net profit down -48.8% at Rs. 29.04 cr. Vs Rs. 56.72 cr. (YoY) and Revenue down -11.4% at Rs. 180.93 cr. Vs Rs. 204.29 cr. (YoY)
Monnet Ispat & Energy Ltd. Q4 Cons: Net loss of Rs. -121.23 cr. Vs loss of Rs. -171.19 cr. (YoY) and Revenue up 15.9% at Rs. 617.31 cr. Vs Rs. 532.82 cr. (YoY)
Gujarat Themis Biosyn Ltd. Q4 : Net profit at Rs. 10.95 cr. Vs Rs. 2.51 cr. (YoY) and Revenue at Rs. 26.35 cr. Vs Rs. 10.35 cr. (YoY)
Board of Directors of the Company has recommended a dividend of Rs. 1.65 per share
Maharashtra Scooters Ltd. Q4 : Net profit at Rs. 107.14 cr. Vs Rs. 6.8 cr. (YoY) and Revenue at Rs. 6.35 cr. Vs Rs. 3.4 cr. (YoY)